Regina Hodits is a Managing Partner at Wellington Partners Life Sciences (WPLS) and represents the WPLS funds on the Boards of AYOXXA, Endostim, GTX Medical, Polares Medical, Themis, and TRiCares. She was a founding investor in Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Middle Peak Medical (acquired by Symetis/ Boston Scientific), and an external director at GlaxoSmithKline’s Respiratory TA Board. Since joining the industry in 2000, she has become an influential investor in the European venture capital industry, focusing on early-stage and growth deals in Life Sciences.